Publications

We work hard to attract, retain, and support the most outstanding faculty.

Circulation

Abstract 001: Perceived Discrimination Is Associated With Abnormal Left Ventricular Structure And Function: The Hispanic Community Health Study/Study Of Latinos: ECHO-SOL Ancillary Study.

2021

Authors: Jonathan M Oxman, Lenny Lopez, Fatima Rodriguez, Linda Gallo, Barry E Hurwitz, Krista Perreira, Martha L Daviglus, Mayank M Kansal, Franklyn Gonzalez, Pamela L Lutsey, Carlos J Rodriguez

Circulation

Abstract P205: A National Study Examining Association Between Frequency Of Cannabis Use And Demographic, Socioeconomic, And Behavioral Risk Factors.

2021

Authors: Abra M Jeffers, Amy Byers, Salomeh Keyhani

Gastrointestinal endoscopy

Endoscopist injury: shifting our focus to interventions.

2021

Authors: Harris-Adamson C, Shergill AK

The New England journal of medicine

Omecamtiv Mecarbil in Systolic Heart Failure. Reply.

2021

Authors: Teerlink JR, Felker GM, McMurray JJV

Clinical trials (London, England)

A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic.

2021

Authors: Keyhani S, Kelly JD, Bent S, Boscardin WJ, Shlipak MG, Leonard S, Abraham A, Lum E, Lau N, Austin C, Oldenburg CE, Zillich A, Lopez L, Zhang Y, Lietman T, Bravata DM

Annals of the rheumatic diseases

POS0226 BIMEKIZUMAB LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY.

2021

Authors: D. Van der Heijde, A. Deodhar, L. S. Gensler, D. Poddubnyy, A. Kivitz, M. Dougados, N. De Peyrecave, M. Oortgiesen, T. Vaux, C. Fleurinck, X. Baraliakos

Annals of the rheumatic diseases

POS1255 REACTOGENICITY OF SARS-COV-2 VACCINES IN PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY DISEASE.

2021

Authors: M. Yang, P. Katz, D. Paez, A. Carvidi, M. Matloubian, M. Nakamura, L. S. Gensler

Annals of the rheumatic diseases

POS0904 FACTORS ASSOCIATED WITH SWITCHING FROM ONE ANTI-TNF AGENT TO ANOTHER ANTI-TNF, OR IL17 AGENT IN PATIENT WITH ANKYLOSING SPONDYLITIS.

2021

Authors: M. Hwang, M. Weisman, L. S. Gensler, A. Tahanan, M. Ishimori, T. Hunter, R. Bolce, J. Lisse, M. Rahbar, M. Shan, J. D. Reveille

Annals of the rheumatic diseases

POS0923 INFLUENCE OF BASELINE DEMOGRAPHICS ON IMPROVEMENTS IN DISEASE ACTIVITY MEASURES IN PATIENTS WITH ANKYLOSING SPONDYLITIS RECEIVING UPADACITINIB: A POST HOC SUBGROUP ANALYSIS OF SELECT-AXIS 1.

2021

Authors: F. Van den Bosch, D. Poddubnyy, J. Stigler, A. Ostor, S. D’angelo, V. Navarro-Compán, I. H. Song, T. Gao, F. Ganz, L. S. Gensler

Annals of the rheumatic diseases

POS0229 DISEASE ACTIVITY AND INFLAMMATION FOLLOWING WITHDRAWAL OF CERTOLIZUMAB PEGOL TREATMENT IN AXIAL SPONDYLOARTHRITIS PATIENTS WHO DID NOT EXPERIENCE FLARES DURING THE C-OPTIMISE STUDY.

2021

Authors: L. S. Gensler, X. Baraliakos, L. Bauer, B. Hoepken, T. Kumke, M. Kim, R. B. M. Landewé